ACHN - Achillion Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
0
15,000
66,122
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
66,122
Operating Expenses
Research Development
55,796
50,118
65,052
59,162
56,553
Selling General and Administrative
20,684
23,896
24,524
20,703
24,676
Total Operating Expenses
76,480
74,014
89,576
79,865
81,229
Operating Income or Loss
-76,480
-74,014
-89,576
-64,865
-15,107
Interest Expense
31
36
50
68
55
Total Other Income/Expenses Net
-730
-1,900
-
0
8,944
Income Before Tax
-70,870
-70,272
-85,236
-61,706
-5,030
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-70,870
-70,272
-85,236
-61,706
-5,030
Net Income
-70,870
-70,272
-85,236
-61,706
-5,030
Net Income available to common shareholders
-70,870
-70,272
-85,236
-61,706
-5,030
Reported EPS
Basic
-
-0.51
-0.62
-0.45
-0.04
Diluted
-
-0.51
-0.62
-0.45
-0.04
Weighted average shares outstanding
Basic
-
138,418
137,180
136,667
125,592
Diluted
-
138,418
137,180
136,667
125,592
EBITDA
-
-70,236
-85,186
-61,638
-4,975